Cargando…

512 Systemic Norepinephrine Impact on Tangential Split Thickness Skin Graft Outcomes in Burn Shock Patients

INTRODUCTION: Blood pressure supporting agents like vasopressors are often used to treat patients with burn shock. Norepinephrine is part of the algorithms used by regional burn centers for fluid resuscitation in burn shock. In our population of burn shock patients, we have noticed an association of...

Descripción completa

Detalles Bibliográficos
Autores principales: Terziyski, Ilina, John, Albin A, Snitman, Annie, Sorensen, Grant, Adams, Callie M, Novello, Matteo, Griswold, John A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945923/
http://dx.doi.org/10.1093/jbcr/irac012.143
_version_ 1784674069909602304
author Terziyski, Ilina
John, Albin A
Snitman, Annie
Sorensen, Grant
Adams, Callie M
Novello, Matteo
Griswold, John A
author_facet Terziyski, Ilina
John, Albin A
Snitman, Annie
Sorensen, Grant
Adams, Callie M
Novello, Matteo
Griswold, John A
author_sort Terziyski, Ilina
collection PubMed
description INTRODUCTION: Blood pressure supporting agents like vasopressors are often used to treat patients with burn shock. Norepinephrine is part of the algorithms used by regional burn centers for fluid resuscitation in burn shock. In our population of burn shock patients, we have noticed an association of poor graft take when norepinephrine is used. We undertook this study to assess the relationship between systemic norepinephrine use and split-thickness skin graft (STSG) healing. METHODS: We retrospectively identified burn patients who presented to our burn center from January 2014 –June 2020, who were treated with systemic vasopressors within the first 48 hours of admission, and received at least one tangential excision and STSG procedure as part of their treatment. We compared these patients to a matched control group of burn patients who did not receive vasopressors for resuscitative purposes. The primary outcome investigated was graft take percentage at time of graft takedown. RESULTS: During the time frame, we found 19 patients and 19 matched controls within the same time period who did not receive norepinephrine. The mean percent graft take for patients treated with systemic norepinephrine was 77.9% (SE = 3.00), which was significantly lower than that of the control group, 92.8% (SE = 3.56) (P= < 0.001). Furthermore, patients who received norepinephrine had a statistically significant increase in both hospital (P= 0.038) and intensive care unit (ICU) length of stay (P= 0.009). The two populations were equivalent in all other characteristics such as TBSA, number of comorbidities, age, and resuscitation volumes. CONCLUSIONS: In this retrospective assessment, the use of norepinephrine seems to have a significant association with worse graft take and longer length of stay. Since graft loss begets more graft reoperations and a longer stay, our findings would lead one to incorporate norepinephrine as a last resort in the treatment algorithm for burn shock.
format Online
Article
Text
id pubmed-8945923
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89459232022-03-28 512 Systemic Norepinephrine Impact on Tangential Split Thickness Skin Graft Outcomes in Burn Shock Patients Terziyski, Ilina John, Albin A Snitman, Annie Sorensen, Grant Adams, Callie M Novello, Matteo Griswold, John A J Burn Care Res Clinical Sciences: Critical Care 1 INTRODUCTION: Blood pressure supporting agents like vasopressors are often used to treat patients with burn shock. Norepinephrine is part of the algorithms used by regional burn centers for fluid resuscitation in burn shock. In our population of burn shock patients, we have noticed an association of poor graft take when norepinephrine is used. We undertook this study to assess the relationship between systemic norepinephrine use and split-thickness skin graft (STSG) healing. METHODS: We retrospectively identified burn patients who presented to our burn center from January 2014 –June 2020, who were treated with systemic vasopressors within the first 48 hours of admission, and received at least one tangential excision and STSG procedure as part of their treatment. We compared these patients to a matched control group of burn patients who did not receive vasopressors for resuscitative purposes. The primary outcome investigated was graft take percentage at time of graft takedown. RESULTS: During the time frame, we found 19 patients and 19 matched controls within the same time period who did not receive norepinephrine. The mean percent graft take for patients treated with systemic norepinephrine was 77.9% (SE = 3.00), which was significantly lower than that of the control group, 92.8% (SE = 3.56) (P= < 0.001). Furthermore, patients who received norepinephrine had a statistically significant increase in both hospital (P= 0.038) and intensive care unit (ICU) length of stay (P= 0.009). The two populations were equivalent in all other characteristics such as TBSA, number of comorbidities, age, and resuscitation volumes. CONCLUSIONS: In this retrospective assessment, the use of norepinephrine seems to have a significant association with worse graft take and longer length of stay. Since graft loss begets more graft reoperations and a longer stay, our findings would lead one to incorporate norepinephrine as a last resort in the treatment algorithm for burn shock. Oxford University Press 2022-03-23 /pmc/articles/PMC8945923/ http://dx.doi.org/10.1093/jbcr/irac012.143 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the American Burn Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Sciences: Critical Care 1
Terziyski, Ilina
John, Albin A
Snitman, Annie
Sorensen, Grant
Adams, Callie M
Novello, Matteo
Griswold, John A
512 Systemic Norepinephrine Impact on Tangential Split Thickness Skin Graft Outcomes in Burn Shock Patients
title 512 Systemic Norepinephrine Impact on Tangential Split Thickness Skin Graft Outcomes in Burn Shock Patients
title_full 512 Systemic Norepinephrine Impact on Tangential Split Thickness Skin Graft Outcomes in Burn Shock Patients
title_fullStr 512 Systemic Norepinephrine Impact on Tangential Split Thickness Skin Graft Outcomes in Burn Shock Patients
title_full_unstemmed 512 Systemic Norepinephrine Impact on Tangential Split Thickness Skin Graft Outcomes in Burn Shock Patients
title_short 512 Systemic Norepinephrine Impact on Tangential Split Thickness Skin Graft Outcomes in Burn Shock Patients
title_sort 512 systemic norepinephrine impact on tangential split thickness skin graft outcomes in burn shock patients
topic Clinical Sciences: Critical Care 1
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945923/
http://dx.doi.org/10.1093/jbcr/irac012.143
work_keys_str_mv AT terziyskiilina 512systemicnorepinephrineimpactontangentialsplitthicknessskingraftoutcomesinburnshockpatients
AT johnalbina 512systemicnorepinephrineimpactontangentialsplitthicknessskingraftoutcomesinburnshockpatients
AT snitmanannie 512systemicnorepinephrineimpactontangentialsplitthicknessskingraftoutcomesinburnshockpatients
AT sorensengrant 512systemicnorepinephrineimpactontangentialsplitthicknessskingraftoutcomesinburnshockpatients
AT adamscalliem 512systemicnorepinephrineimpactontangentialsplitthicknessskingraftoutcomesinburnshockpatients
AT novellomatteo 512systemicnorepinephrineimpactontangentialsplitthicknessskingraftoutcomesinburnshockpatients
AT griswoldjohna 512systemicnorepinephrineimpactontangentialsplitthicknessskingraftoutcomesinburnshockpatients